Weber Valley Dialysis (DVA) in Ogden, Utah - Dialysis Center

Weber Valley Dialysis (DVA) is a medicare approved dialysis facility center in Ogden, Utah and it has 13 dialysis stations. It is located in Weber county at 1920 W 250 N, Ogden, UT, 84404. You can reach out to the office of Weber Valley Dialysis (DVA) at (801) 731-4178. This dialysis clinic is managed and/or owned by Davita. Weber Valley Dialysis (DVA) has the following ownership type - Profit. It was first certified by medicare in August, 2008. The medicare id for this facility is 462539 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameWeber Valley Dialysis (DVA)
Location1920 W 250 N, Ogden, Utah
No. of Dialysis Stations 13
Medicare ID462539
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


1920 W 250 N, Ogden, Utah, 84404
(801) 731-4178

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Weber Valley Dialysis (DVA) from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1023284171
Organization NameWeber Valley Dialysis
Doing Business AsTotal Renal Care Inc
Address1920 W 250 N Marriott-slaterville City, Utah, 84404
Phone Number(801) 731-4178

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data10

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center19
    Adult patient months included in Kt/V greater than or equal to 1.2179
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Purdue University startup receives NIH grant to advance Alzheimer's research

    A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

    Findings reveal variations between countries and regions in use of HSCT procedure

    Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

    Surface analysis exposes counterfeit medicines

    CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

    New grants could help protect the environment and create new therapy for Parkinson's

    New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Weber Valley Dialysis (DVA) with elevated calcium levels.

Patients with hypercalcemia22
Hypercalcemia patient months211
Patients with Serumphosphor23
Patients with Serumphosphor less than 3.5 mg/dL11
Patients with Serumphosphor from 3.5 to 4.5 mg/dL18
Patients with Serumphosphor from 4.6 to 5.5 mg/dL34
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 24
Patient months included in arterial venous fistula and catheter summaries 146
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment98
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer1

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary20
Hospitalization Rate in facility80.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit309.4
Hospitalization Rate: Lower Confidence Limit23.2

News Archive

Purdue University startup receives NIH grant to advance Alzheimer's research

A $2 million grant from the National Institute on Aging at the National Institutes of Health to Neurodon, a Purdue University-affiliated startup, will help fast-track molecules that could improve memory and reduce Alzheimer's disease neurodegeneration.

Findings reveal variations between countries and regions in use of HSCT procedure

Since the first experimental bone marrow transplant over 50 years ago, more than one million hematopoietic stem cell transplantations (HSCT) have been performed in 75 countries, according to new research charting the remarkable growth in the worldwide use of HSCT, published in The Lancet Haematology journal.

Surface analysis exposes counterfeit medicines

CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.

New grants could help protect the environment and create new therapy for Parkinson's

New grants from the State University of New York could help researchers at Binghamton University create a new therapy to provide relief to Parkinson's patients and help locate abandoned oil and gas wells.

Read more Medical News

› Verified 3 days ago